These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17854871)

  • 41. Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo.
    Shentu J; Zhang B; Fan L; He Q; Yang B; Chen Z
    Anticancer Drugs; 2007 Jan; 18(1):47-53. PubMed ID: 17159502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
    Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
    Supino R; Crosti M; Clerici M; Warlters A; Cleris L; Zunino F; Formelli F
    Int J Cancer; 1996 Feb; 65(4):491-7. PubMed ID: 8621233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fenretinide and its relation to cancer.
    Ulukaya E; Wood EJ
    Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
    Hsu YL; Kuo PL; Tzeng TF; Sung SC; Yen MH; Lin LT; Lin CC
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e290-9. PubMed ID: 18522681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthetic retinoids as inducers of apoptosis in ovarian carcinoma cell lines.
    Holmes WF; Soprano DR; Soprano KJ
    J Cell Physiol; 2004 Jun; 199(3):317-29. PubMed ID: 15095280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
    Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
    Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
    Ruan HY; Li DR; Li L; Guan X; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and targeting of interleukin-4 receptor for primary and advanced ovarian cancer therapy.
    Kioi M; Takahashi S; Kawakami M; Kawakami K; Kreitman RJ; Puri RK
    Cancer Res; 2005 Sep; 65(18):8388-96. PubMed ID: 16166317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endogenous fluorescence spectroscopy of cell suspensions for chemopreventive drug monitoring.
    Kirkpatrick ND; Zou C; Brewer MA; Brands WR; Drezek RA; Utzinger U
    Photochem Photobiol; 2005; 81(1):125-34. PubMed ID: 15535738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of hedgehog signaling in ovarian cancer.
    Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
    Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production.
    Andrews WJ; Winnett G; Rehman F; Shanmugasundaram P; Hagen Dv; Schrey MP
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):159-65. PubMed ID: 15862961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of Omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines.
    Sharma A; Belna J; Logan J; Espat J; Hurteau JA
    Gynecol Oncol; 2005 Oct; 99(1):58-64. PubMed ID: 16043214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.
    Sabichi AL; Hendricks DT; Bober MA; Birrer MJ
    J Natl Cancer Inst; 1998 Apr; 90(8):597-605. PubMed ID: 9554442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.
    Hongo A; Kuramoto H; Nakamura Y; Hasegawa K; Nakamura K; Kodama J; Hiramatsu Y
    Cancer Res; 2003 Nov; 63(22):7834-9. PubMed ID: 14633710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
    Li C; Yu DF; Newman RA; Cabral F; Stephens LC; Hunter N; Milas L; Wallace S
    Cancer Res; 1998 Jun; 58(11):2404-9. PubMed ID: 9622081
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dynamic progression of an intraperitoneal xenograft model of human ovarian cancer and its potential for preclinical trials.
    Lin XJ; Chen XC; Wang L; Wei YQ; Kan B; Wen YJ; He X; Zhao X
    J Exp Clin Cancer Res; 2007 Dec; 26(4):467-74. PubMed ID: 18365540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
    Pagnan G; Di Paolo D; Carosio R; Pastorino F; Marimpietri D; Brignole C; Pezzolo A; Loi M; Galietta LJ; Piccardi F; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M
    Clin Cancer Res; 2009 Feb; 15(4):1199-209. PubMed ID: 19228726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.